I would like to share the story of how a patient with cancer came up with the idea for a randomized trial, & how listening to him saved a lot of lives. 1/ In 2002, I had just completed a randomized trial with the notorious drug thalidomide for the cancer, multiple myeloma.

It's not the lack of intelligence, it's the lack of focus that is stopping you.

Thank you so much for your inspirational leadership and endless support for the WHO Youth Council Tedros Adhanom Ghebreyesus.

Starting #PMAC 2nd day super fresh with talks on giving youth places on the table. A passionate panel with some of my favorite speakers on board Mohamed M. Eissa Omnia El Omrani

A panel on food system transformation at #PMAC2023 "It could be true that people don't wanna shift their diet, but our options will be limited if we don't take action now" coming from Prof.Jessica Fanzo Johns Hopkins Bloomberg School of Public Health

People's Health Movement | @who-watch.bsky.social is in fact a cohost of #PMAC2023. It’s okay if she’s emotional that the health sector is having conversations with the #oilandgas industry. But all conversations have a purpose here. At least, she should respect other cohosts/organizers, including her own organization!

About 99.82% of global land area is exposed to levels of particulate matter 2.5 — tiny particles in the air that scientists have linked to lung cancer and heart disease — above the safety limit recommended by the WHO, according to the peer-reviewed study. japantimes.co.jp/news/2023/03/0…

Today our important study on air pollutants in the promotion of lung cancer has been published in nature led by Will Hill Emilia Lim Clare Weeden Swanton Lab ...Thread below🧵nature.com/articles/s4158…

Tumour promotion was first proposed by Berenblum & Shubik and developed by Allan Balmain and others. Thank you to Prof Balmain for this excellent N&V nature.com/articles/d4158…

If risk factors are not driving cancer by a mutagenic mechanism, how are they acting? This paper by Riva et al suggests many Indian Republican carcinogens could act in a non-mutagenic way. nature.com/articles/s4158…

Submitted my application to #ESMO course for medical student today. Incredibly excited and keeping my fingers crossed for the end of May!

In this paper published today JCO Global Oncology we describe lessons learned from a survey of Canadian GPOs on how GPs can be effectively trained and utilized under the task-sharing and task-shifting models to care for an patients with cancer. ascopubs.org/doi/full/10.12… Queen’s Global Oncology Program

BREAKING NEWS: Alarmed by increasing diagnoses in young women and high death rates in Black women, the U.S. Preventive Services Task Force is recommending all women at average risk for breast cancer get their regular mammograms at age 40 instead of age 50. nytimes.com/2023/05/09/hea…

I am so thrilled and happy to share that I have couples matched at Mayo Clinic Rochester Cardiology Fellows Mayo Clinic CV for #CardiologyFellowship with my partner Pitchaya (Tao) Worapongsatitaya, MD!!! Can’t wait to start our next journey together 😊 #Match2024

I walked into a patient’s room today, and the patient’s mom asked, “Are you the surgeon who braids hair?” “Yes! Yes I am!” 😊 “We heard all about you! We are so excited!!” 🥹🥹🥹 Another little patient of mine jumped out of their bed and came straight to me to give (1/3)

🔥🚨Hot off the press. The #FDA approves 1st line #Osimertinib WITH chemotherapy for advanced #EGFRm non-small cell #LungCancer. Approval based on #FLAURA2 trial which showed ⬆️#PFS compared to #Osimertinib alone. HR: 0.62 mPFS: 25.5 vs 16.7 months 👇🏼 fda.gov/drugs/resource…

Out in JAMA huge academic effort to clarify role of #TILs tumor-infiltrating lymphocytes to avoid #chemotherapy in some patients with triple-negative #BreastCancer: honored & grateful to have Università di Genova Ospedale San Martino Genova part of it! OncoAlert #bcsm jamanetwork.com/journals/jama/…

My med student just asked if NK cells are a type of T cell!!! 😭😭💔💔 like a dagger through my heart.

Answer: according to a recent large study, over 80% of HER2-zero (IHC 0) breast cancers actually exhibit some staining, qualifying for being considered HER2-ultralow. Ref: link.springer.com/content/pdf/10…